ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Treatment of metastatic medullary thyroid cancer with vandetanib: need to stratify patients on basis of calcitonin doubling time.

Jean-François Chatal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.